Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. | Director | Common Stock | 898K | $736K | $0.82 | Feb 28, 2022 | By Spouse |
Karyopharm Therapeutics Inc. | Director | Common Stock | 714K | $585K | $0.82 | Feb 28, 2022 | Direct |
Verastem, Inc. | Director | Common Stock | 8.88K | $28.5K | $3.21 | Jun 18, 2024 | Direct |
Adicet Bio, Inc. | Director | Common Stock | 5.9K | $8.44K | $1.43 | Jun 5, 2024 | Direct |
Kezar Life Sciences, Inc. | Director | Stock Option (right to buy) | 50K | Jun 20, 2024 | Direct | ||
Karyopharm Therapeutics Inc. | Director | Stock Option (right to buy) | 27K | Feb 28, 2022 | Direct | ||
Adicet Bio, Inc. | Director | Stock Option (Right to Buy) | 26.4K | Aug 21, 2024 | Direct | ||
Verastem, Inc. | Director | Stock Option (right to buy) | 12.5K | Jun 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACET | Adicet Bio, Inc. | Aug 21, 2024 | 6 | $0 | 4 | Aug 23, 2024 | Director |
KZR | Kezar Life Sciences, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
VSTM | Verastem, Inc. | Jun 18, 2024 | 2 | $0 | 4 | Jun 20, 2024 | Director |
ACET | Adicet Bio, Inc. | Jun 5, 2024 | 3 | -$8.44K | 4 | Jun 7, 2024 | Director |
VSTM | Verastem, Inc. | Mar 11, 2024 | 9 | $0 | 4 | Mar 13, 2024 | Director |
ACET | Adicet Bio, Inc. | Aug 14, 2023 | 6 | $0 | 4 | Aug 16, 2023 | Director |
KZR | Kezar Life Sciences, Inc. | Jul 24, 2023 | 8 | $0 | 4 | Jul 26, 2023 | Director |
KZR | Kezar Life Sciences, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
ACET | Adicet Bio, Inc. | Jun 1, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Director |
VSTM | Verastem, Inc. | May 15, 2023 | 1 | $0 | 4 | May 16, 2023 | Director |
VSTM | Verastem, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
KZR | Kezar Life Sciences, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
ACET | Adicet Bio, Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
VSTM | Verastem, Inc. | May 12, 2022 | 1 | $0 | 4/A | Dec 20, 2022 | Director |
KPTI | Karyopharm Therapeutics Inc. | Feb 28, 2022 | 4 | -$127K | 4 | Mar 2, 2022 | Director |
KPTI | Karyopharm Therapeutics Inc. | Feb 17, 2022 | 2 | -$220K | 4 | Feb 22, 2022 | Director |
KPTI | Karyopharm Therapeutics Inc. | Feb 7, 2022 | 2 | -$133K | 4 | Feb 9, 2022 | Director |
KZR | Kezar Life Sciences, Inc. | Jan 3, 2022 | 3 | -$52.7K | 4 | Jan 5, 2022 | Director |
ACET | Adicet Bio, Inc. | Nov 17, 2021 | 1 | $0 | 4 | Nov 18, 2021 | Director |
ACET | Adicet Bio, Inc. | Nov 17, 2021 | 0 | $0 | 3 | Nov 18, 2021 | Director |
KZR | Kezar Life Sciences, Inc. | Jun 28, 2021 | 1 | $0 | 4 | Jun 30, 2021 | Director |
VSTM | Verastem, Inc. | Jun 28, 2021 | 1 | $0 | 4 | Jun 30, 2021 | Director |